Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Journal of Medical Virology|June 20, 2012
In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infectionLiza M Cabuang, Tim Shaw, Margaret Littlejohn, et al.Journal of Gastroenterology and Hepatology|July 5, 2007
Lamivudine resistance in patients with chronic hepatitis B: role of clinical and virological factorsAlexander J V Thompson, Anna Ayres, Lilly Yuen, et al.Plos One|July 31, 2014
Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesisSarah R Calabro, Annette E Maczurek, Alison J Morgan, et al.Hepatology (Baltimore, Md.)|June 1, 2010
Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markersAlexander J V Thompson, Tin Nguyen, David Iser, et al.Science Translational Medicine|September 29, 2017
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAgChristine I Wooddell, Man-Fung Yuen, Henry Lik-Yuen Chan, et al.Virology|July 27, 2010
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencingJennifer Audsley, Margaret Littlejohn, Lilly Yuen, et al.Hepatology (Baltimore, Md.)|October 27, 2019
RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B InfectionMan-Fung Yuen, Ingolf Schiefke, Jung-Hwan Yoon, et al.Journal of Virology|November 11, 2011
Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative diseaseChristopher P Desmond, Silvana Gaudieri, Ian R James, et al.Hepatology (Baltimore, Md.)|August 12, 2020
Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease PhaseJosef Wagner, Lilly Yuen, Margaret Littlejohn, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 27, 2022
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis BMan-Fung Yuen, Chi-Yi Chen, Chun-Jen Liu, et al.Pageof 6